Completed NA INTERVENTIONAL 1-arm NCT05036200

Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma (PDL)

Efficacy, Tolerance and Acceptability of Pulsed Dye Laser on Telangiectasias of the Face and Neckline in Systemic Scleroderma: a Prospective Single-center Open-label Study of 21 Patients

Sponsor: University Hospital, Caen

Conditions Telangiectasia

Interventions pulsed dye laser

Updated 3 times since 2021 Last updated: Aug 30, 2021 Started: Aug 1, 2019 Primary completion: Sep 1, 2019 Completion: Jul 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Telangiectasia, this trial is completed. The trial is conducted by University Hospital, Caen and has accumulated 3 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Caen

Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caen, France